28-Jan-2022 By Jenni Spinner
A representative from IQVIA discusses the particulars of the US agency’s new draft document and shares what it might mean for clinical trial data evaluation.
Source: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/01/28/NEW-FDA-DRAFT-GUIDANCE-DOCUMENT-GETS-REAL-ABOUT-RWD-USE